Tech Company Financing Transactions

Ilypsa Funding Round

On 7/19/2005, Ilypsa raised $36 million in Series B funding from Delphi Ventures, Johnson & Johnson Development Corporation and U.S. Venture Partners.

Transaction Overview

Company Name
Announced On
7/19/2005
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series B
Investors

Delphi Ventures (Lead Investor) (Deepa Pakianathan)

Johnson & Johnson Development Corporation (Lead Investor) (Brad Vale)

U.S. Venture Partners (Lead Investor) (Jonathan Root)

5AM Ventures

Mediphase Venture Partners

Presidio Partners

Sprout Group

Proceeds Purpose
Ilypsa will use the funds to complete preclinical and initiate clinical development of their two lead compounds ILY-101, a metal-free, polymeric phosphate binder, and ILY-105, a novel potassium-binding polymer.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3406 Central Expressway
Santa Clara, CA 95051
USA
Email Address
Not Recorded
Overview
Ilypsa, Inc. is a biopharmaceutical company focused on developing a proprietary pipeline of novel non-absorbed polymeric drugs for important therapeutic applications.
Profile
Ilypsa LinkedIn Company Profile
Social Media
Ilypsa Company Twitter Account
Company News
Ilypsa News
Facebook
Ilypsa on Facebook
YouTube
Ilypsa on YouTube

Management Team

Title
Name
Email & Social
Chairman
Scott Rocklage
  Scott Rocklage LinkedIn Profile  Scott Rocklage Twitter Account  Scott Rocklage News  Scott Rocklage on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/19/2005: WaveMaker Software venture capital transaction
Next: 7/19/2005: Solicore venture capital transaction

 

Share this article

 


About Database of VC Transactions

We record funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary